|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Korwin J-D: Epidemiology of
Helicobacter pylori infection and gastric cancer. Rev Prat.
64:189–193. 2014.(In French). PubMed/NCBI
|
|
3
|
Munn LL: Cancer and inflammation. Wiley
Interdiscip Rev Syst Biol Med. 9:e13702017. View Article : Google Scholar
|
|
4
|
Vohlonen I, Pukkala E, Malila N, Härkönen
M, Hakama M, Koistinen V and Sipponen P: Risk of gastric cancer in
Helicobacter pylori infection in a 15-year follow-up. Scand J
Gastroenterol. 51:1159–1164. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jozkowicz A, Was H and Dulak J: Heme
oxygenase-1 in tumors: Is it a false friend? Antioxid Redox Signal.
9:2099–2117. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yin H, Fang J, Liao L, Maeda H and Su Q:
Upregulation of heme oxygenase-1 in colorectal cancer patients with
increased circulation carbon monoxide levels, potentially affects
chemotherapeutic sensitivity. BMC Cancer. 14:4362014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Degese MS, Mendizabal JE, Gandini NA,
Gutkind JS, Molinolo A, Hewitt SM, Curino AC, Coso OA and
Facchinetti MM: Expression of heme oxygenase-1 in non-small cell
lung cancer (NSCLC) and its correlation with clinical data. Lung
Cancer. 77:168–175. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Noh SJ, Bae JS, Jamiyandorj U, Park HS,
Kwon KS, Jung SH, Youn HJ, Lee H, Park BH, Chung MJ, et al:
Expression of nerve growth factor and heme oxygenase-1 predict poor
survival of breast carcinoma patients. BMC Cancer. 13:5162013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wegiel B, Nemeth Z, Correa-Costa M, Bulmer
AC and Otterbein LE: Heme oxygenase-1: A metabolic nike. Antioxid
Redox Signal. 20:1709–1722. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lundvig DM, Immenschuh S and Wagener FA:
Heme oxygenase, inflammation, and fibrosis: The good, the bad, and
the ugly? Front Pharmacol. 3(81)2012.PubMed/NCBI
|
|
11
|
Ivanov AV, Valuev-Elliston VT, Tyurina DA,
Ivanova ON, Kochetkov SN, Bartosch B and Isaguliants MG: Oxidative
stress, a trigger of hepatitis C and B virus-induced liver
carcinogenesis. Oncotarget. 8:3895–3932. 2017.PubMed/NCBI
|
|
12
|
Liao YF, Zhu W, Li DP and Zhu X: Heme
oxygenase-1 and gut ischemia/reperfusion injury: A short review.
World J Gastroenterol. 19:3555–3561. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Strasser-Weippl K and Ludwig H: Ferritin
as prognostic marker in multiple myeloma patients undergoing
autologous transplantation. Leuk Lymphoma. 55:2520–2524. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Torti SV and Torti FM: Iron and cancer:
More ore to be mined. Nat Rev Cancer. 13:342–355. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng J, Nagda DA, Lajud SA, Kumar S,
Mouchli A, Bezpalko O, O'Malley BW Jr and Li D: Biliverdin's
regulation of reactive oxygen species signalling leads to potent
inhibition of proliferative and angiogenic pathways in head and
neck cancer. Br J Cancer. 110:2116–2122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang SL, Liu LP, Jiang JX, Xiong ZF, He QJ
and Wu C: The correlation of expression levels of HIF-1α and HIF-2α
in hepatocellular carcinoma with capsular invasion, portal vein
tumor thrombi and patients' clinical outcome. Jpn J Clin Oncol.
44:159–167. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu JL, Xiao L, Li ZY, Wang Q, Chang Y and
Jin Y: Upregulation of HO-1 is accompanied by activation of p38MAPK
and mTOR in human oesophageal squamous carcinoma cells. Cell Biol
Int. 37:584–592. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Furfaro AL, Traverso N, Domenicotti C,
Piras S, Moretta L, Marinari UM, Pronzato MA and Nitti M: The
Nrf2/HO-1 axis in cancer cell growth and chemoresistance. Oxid Med
Cell Longev. 2016:19581742016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Trachootham D, Alexandre J and Huang P:
Targeting cancer cells by ROS-mediated mechanisms: A radical
therapeutic approach? Nat Rev Drug Discov. 8:579–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alaoui-Jamali MA, Gupta A, Szarek WA,
Bismar TA, Gheorghe R and Schipper HM: A novel selective
therapeutic targeting heme oxygenase-1 revealed a potent
antimetastatic activity in androgen-refractory human prostate
cancer models. J Clin Oncol. 27:e160902009.doi:
10.1200/jco.2009.27.15s.e16090.
|
|
21
|
Liu ZM, Chen GG, Ng EKW, Leung WK, Sung
JJY and Chung SCS: Upregulation of heme oxygenase-1 and p21 confers
resistance to apoptosis in human gastric cancer cells. Oncogene.
23:503–513. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Motovali-Bashi M and Hamidy M: Association
between GT-repeat polymorphism at heme oxygenase-1 gene promoter
and gastric cancer and metastasis. Tumour Biol. 36:4757–4762. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yin Y, Liu Q, Wang B, Chen G, Xu L and
Zhou H: Expression and function of heme oxygenase-1 in human
gastric cancer. Exp Biol Med (Maywood). 237:362–371. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mayerhofer M, Florian S, Krauth MT,
Aichberger KJ, Bilban M, Marculescu R, Printz D, Fritsch G, Wagner
O, Selzer E, et al: Identification of heme oxygenase-1 as a novel
BCR/ABL-dependent survival factor in chronic myeloid leukemia.
Cancer Res. 64:3148–3154. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Heasman SA, Zaitseva L, Bowles KM,
Rushworth SA and Macewan DJ: Protection of acute myeloid leukaemia
cells from apoptosis induced by front-line chemotherapeutics is
mediated by haem oxygenase-1. Oncotarget. 2:658–668. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Berberat PO, Dambrauskas Z, Gulbinas A,
Giese T, Giese N, Künzli B, Autschbach F, Meuer S, Büchler MW and
Friess H: Inhibition of heme oxygenase-1 increases responsiveness
of pancreatic cancer cells to anticancer treatment. Clin Cancer
Res. 11:3790–3798. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miyake M, Ishii M, Kawashima K, Kodama T,
Sugano K, Fujimoto K and Hirao Y: siRNA-mediated knockdown of the
heme synthesis and degradation pathways: Modulation of treatment
effect of 5-aminolevulinic acid-based photodynamic therapy in
urothelial cancer cell lines. Photochem Photobiol. 85:1020–1027.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Miyake M, Fujimoto K, Anai S, Ohnishi S,
Nakai Y, Inoue T, Matsumura Y, Tomioka A, Ikeda T, Okajima E, et
al: Inhibition of heme oxygenase-1 enhances the cytotoxic effect of
gemcitabine in urothelial cancer cells. Anticancer Res.
30:2145–2152. 2010.PubMed/NCBI
|
|
29
|
Jeon WK, Hong HY, Seo WC, Lim KH, Lee HY,
Kim WJ, Song SY and Kim BC: Smad7 sensitizes A549 lung cancer cells
to cisplatin-induced apoptosis through heme oxygenase-1 inhibition.
Biochem Biophys Res Commun. 420:288–292. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang W, Qiao T and Zha L: Inhibition of
heme oxygenase-1 enhances the radiosensitivity in human nonsmall
cell lung cancer a549 cells. Cancer Biother Radiopharm. 26:639–645.
2011. View Article : Google Scholar : PubMed/NCBI
|
